HCV seroconversion panels supporting early assay development and validation
Early detection remains a key objective in the development of hepatitis C virus (HCV) diagnostic assays. Determining how early antibodies can be detected following infection requires high-quality, well-characterized seroconversion panels that accurately reflect the course of the immune response. Recent independent clinical evaluations of novel anti-HCV immunoassays have included BIOMEX HCV seroconversion panels to assess Read More
BIOMEX at ADLM 2026!
From July 28–30, 2026, BIOMEX will be exhibiting at ADLM 2026 in Anaheim, California. Visit us at Booth #4049 to discover how we help researchers and IVD manufacturers accelerate their projects with reliable access to high-quality human biospecimens. Supporting diagnostics from sample sourcing to clinical studies Together with our sister company IVD TRIALS, we offer Read More
HIV seroconversion panels: supporting reliable early detection and assay validation
Early detection is one of the most critical performance characteristics of modern HIV diagnostic assays. To accurately evaluate analytical sensitivity and determine how early an infection can be detected, developers rely on high-quality, well-characterized seroconversion panels. Recent peer-reviewed studies demonstrate how BIOMEX HIV seroconversion panels have supported the development and validation of HIV assays by Read More
Why high-quality leukopaks matter for reliable immune cell research
Reproducibility remains one of the greatest challenges in immune cell research and cell & gene therapy development. While many factors influence experimental outcomes, one critical aspect is often overlooked: the quality of the leukopak used as starting material. Human leukopaks form the foundation of numerous immune cell-based applications, from early-stage assay development and biomarker research Read More
BIOMEX at EACR 2026!
We’re excited to be attending the European Association for Cancer Research (EACR) Congress 2026 in Hashtag#Budapest from June 8–11, 2026! Visit us at Booth #74 and meet our experts on site: Dr. Susanna Maria Lissek & Dr. Robert Rusch We are looking forward to many inspiring conversations about your cancer research projects and discussing how Read More
Only a few days to go until CIMT 2026!
Only a few days to go until CIMT 2026! At BIOMEX, we support personalized immunotherapy through comprehensive in-house donor characterization and assay capabilities, from immune profiling to functional testing. Visit us at Booth #5 and connect with our Sales Experts, Dr. Robert Rusch and Melosha Puspathasan, to discuss how BIOMEX can support your immunotherapy and Read More
Central BioHub continues under BIOMEX
Central BioHub continues with a clear focus on human biospecimens. As part of the insolvency proceedings of Central BioHub GmbH, BIOMEX has acquired the trademark rights to “Central BioHub.” Today, the Central BioHub brand stands for reliable access to high quality human biospecimens, supported by BIOMEX’s established infrastructure. Customers can source #wholeblood, #plasma, #serum, #CSF, Read More
BIOMEX at the DGMB Annual Meeting 2026 in Heidelberg
From April 15–17, BIOMEX will be participating in the annual meeting of the Deutsche Gesellschaft für Matrixbiologie (DGMB) e.V. in Heidelberg – contributing to the scientific dialogue shaping the future of matrix biology. A key highlight of the event will be the presentation by our scientist Dr. Jasmina Paluncic, taking place on Wednesday, April 15th Read More
BIOMEX at CACLP 2026
What an inspiring few days at CACLP 2026! BIOMEX was delighted to be part of this year’s event and to connect with the global diagnostics community. At our booth, we had the pleasure of meeting numerous partners, customers, and new contacts, engaging in meaningful discussions about current challenges and future opportunities in the diagnostics field. Read More
BIOMEX Exhibits at CACLP 2026
BIOMEX is pleased to announce that we will be exhibiting at CACLP 2026, taking place March 21–23, 2026, in China. We will be present together with our sister company IVD TRIALS. Visitors will have the opportunity to learn more about BIOMEX’s high-quality biospecimens as well as the comprehensive IVDR expertise and validation studies offered by Read More